Boston Scientific buys nVision Medical for $275 million
April 17, 2018 at 10:54 AM EDT
California-based nVision makes a microcatheter device used to screen for ovarian cancer.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.